ALK and non-small cell lung carcinoma: These rearrangements result in ligand-independent dimerization and sustained hyperactivation of ALK, which in turn drives pro-mitogenic and anti-apoptotic signaling pathways, thereby facilitating tumor progression.12–14 In NSCLC, structural fusions involving ALK gene rearrangements are of critical importance.